Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative binding models for CYP2C9 based on benzbromarone analogues.

Charles W Locuson1, Denise A Rock, Jeffrey P Jones

  • 1School of Molecular Biosciences, Washington State University, Pullman, Washington 99164, USA.

Biochemistry
|June 2, 2004
PubMed
Summary

Understanding cytochrome P450 (CYP) enzyme specificity is crucial for drug development. This study reveals that specific bulky hydrophobic groups and anionic charges significantly enhance inhibitor binding to CYP2C9, improving drug design strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enzyme Kinetics, Pharmacokinetics, and Inhibition of Aldehyde Oxidase.

Methods in molecular biology (Clifton, N.J.)·2021
Same author

Multiple-dose pharmacokinetics and opioid effects of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs.

American journal of veterinary research·2021
Same author

Aldehyde Oxidase Contributes to All-<i>Trans</i>-Retinoic Acid Biosynthesis in Human Liver.

Drug metabolism and disposition: the biological fate of chemicals·2020
Same author

Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey.

Drug metabolism and disposition: the biological fate of chemicals·2020
Same author

Pharmacokinetics and pharmacodynamics of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs.

American journal of veterinary research·2020
Same author

Numerical Analysis of Time-Dependent Inhibition by MDMA.

Drug metabolism and disposition: the biological fate of chemicals·2019

Area of Science:

  • Biochemistry
  • Pharmacology
  • Enzymology

Background:

  • Cytochrome P450 (CYP) enzymes are critical for xenobiotic metabolism.
  • Predicting substrate selectivity for CYP isoforms like CYP2C9 is challenging due to enzyme flexibility and broad substrate ranges.

Purpose of the Study:

  • To elucidate the key determinants of specificity for the CYP2C9 enzyme.
  • To re-evaluate the pharmacophore of benzbromarone (bzbr) inhibitors for improved CYP2C9 interaction.

Main Methods:

  • Utilized a novel library of benzbromarone (bzbr) analogues as inhibitors.
  • Employed Comparative Molecular Similarity Indices Analysis (CoMSIA) to generate binding models and 3D contour plots.
  • Integrated mutagenesis and structural data with computational modeling.

Related Experiment Videos

Main Results:

  • Identified specific electrostatic and hydrophobic interactions as primary contributors to CYP2C9 specificity.
  • Demonstrated that analogues with bulky groups adjacent to the phenol and increased pK(a) values exhibit higher affinity.
  • CoMSIA models suggest favorable hydrophobicity from bulky groups and a preference for negative charge at the ketone oxygen.

Conclusions:

  • Bulky hydrophobic groups and anionic character are critical for high-affinity binding to CYP2C9.
  • The ketone oxygen acts as a key positive charge acceptor, influencing interactions with other CYP2C9 substrates.
  • Findings provide insights for designing more potent and selective CYP2C9 inhibitors.